Agent model of latency. by John M. Murray (150672)

Reservoir dynamics. by John M. Murray (150672)

Percentage of singletons and median clone size. by John M. Murray (150672)

Cells contributing to residual viremia. by John M. Murray (150672)

Number and size of clonal populations. by John M. Murray (150672)

Clone size distributions. by John M. Murray (150672)

Histograms of clonal sizes for the individual simulation with parameters as described in Fig 8. by John M. Murray (150672)

Reservoir and pVL dynamics for the parameter set that best reproduced the year 11.4 ART clone profile. by John M. Murray (150672)

Continuous Viscoelasticity Measurement of Cell Spheroids via Microfluidic Electrical Aspiration by Heyi Chen (19930197)

Subjects:

The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

Percentage decrease in model output peak with the administration of exogenous estrogen/progesterone. by Brenda Lyn A. Gavina (15285185)

Dramatic Lockdown Fossil Fuel CO₂ Decrease Detected by Citizen Science-Supported Atmospheric Radiocarbon Observations by Jocelyn C. Turnbull (6083705)

Schematic of Large-Scale Filtration System (LSFS). by Haedi E. DeAngelis (10652168)

Fig 3 - by Claire Gauquelin Des Pallieres (15333248)

Data_Sheet_1_Association Between Plasma Exosomes S100A9/C4BPA and Latent Tuberculosis Infection Treatment: Proteomic Analysis Based on a Randomized Controlled Study.docx by Ying Du (42066)

“…Eligible participants for both screening and verification sets were randomly selected from the based-RCT in a 1:1 ratio by age and gender. Reversion was defined as a decrease in IFN-γ levels from >0.70 IU/ml prior to treatment to 0.20 IU/ml within 1 week of treatment. …”

Data_Sheet_2_Association Between Plasma Exosomes S100A9/C4BPA and Latent Tuberculosis Infection Treatment: Proteomic Analysis Based on a Randomized Controlled Study.docx by Ying Du (42066)

“…Eligible participants for both screening and verification sets were randomly selected from the based-RCT in a 1:1 ratio by age and gender. Reversion was defined as a decrease in IFN-γ levels from >0.70 IU/ml prior to treatment to 0.20 IU/ml within 1 week of treatment. …”

Image_9_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

“…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…”

Image_3_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

“…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…”

Image_5_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIF by Zhixing Kuang (10809975)

“…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…”

Image_10_Comprehensive Characterization of Cachexia-Inducing Factors in Diffuse Large B-Cell Lymphoma Reveals a Molecular Subtype and a Prognosis-Related Signature.TIFF by Zhixing Kuang (10809975)

“…Cachexia-inducing factors (CIFs) have been reported in colorectal cancer and pancreatic adenocarcinoma, but their value in diffuse large B-cell lymphoma (DLBCL) requires further genetic research.…”